Catalyst Wire Dossier Catalyst Wire Dossier

Tacrolimus topical ointment 0.03%

tacrolimus · Assaf-Harofeh Medical Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tacrolimus topical ointment 0.03%, covering 2007-03-05 to 2007-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study [Phase 2]

See pricing